Search research articles
Contact Us
Filters
Showing results (601-610 of 1,833) with videos related to
Page
of 184
Sort By:
Mabs
|
November 25, 2010
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
Stuart L Emanuel, Linda J Engle, Ginger Chao, et al.
Mabs
|
February 10, 2011
A tool for increasing the lifetime of chromatography resins
Anna Grönberg, Malin Eriksson, Maria Ersoy, et al.
Mabs
|
June 10, 2011
Bispecific antibodies and ADCs: Once and future kings?
Janice M Reichert
Mabs
|
November 30, 2011
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
Gregory L Moore, Cristina Bautista, Erik Pong, et al.
Mabs
|
November 30, 2011
The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge
Randall J Brezski, Allison Oberholtzer, Brandy Strake, et al.
Mabs
|
November 30, 2011
An innovative approach for the characterization of the isoforms of a monoclonal antibody product
Shanmuuga Sundaram, Alice Matathia, Jun Qian, et al.
Mabs
|
November 30, 2011
The impact of glycosylation on monoclonal antibody conformation and stability
Kai Zheng, Christopher Bantog, Robert Bayer
Mabs
|
November 30, 2011
Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
Jacqueline M Benson, David Peritt, Bernard J Scallon, et al.
Mabs
|
November 30, 2011
Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions
Yuniel Fernández-Marrero, Alejandro López-Requena
Mabs
|
November 30, 2011
Aggregation, immune complexes and immunogenicity
Roy Jefferis
Page
of 184
Search research articles
Search
Showing results (601-610 of 1,833) with videos related to
Sort By:
Page
of 184
Mabs
|
November 25, 2010
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
Stuart L Emanuel, Linda J Engle, Ginger Chao, et al.
Mabs
|
February 10, 2011
A tool for increasing the lifetime of chromatography resins
Anna Grönberg, Malin Eriksson, Maria Ersoy, et al.
Mabs
|
June 10, 2011
Bispecific antibodies and ADCs: Once and future kings?
Janice M Reichert
Mabs
|
November 30, 2011
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
Gregory L Moore, Cristina Bautista, Erik Pong, et al.
Mabs
|
November 30, 2011
The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge
Randall J Brezski, Allison Oberholtzer, Brandy Strake, et al.
Mabs
|
November 30, 2011
An innovative approach for the characterization of the isoforms of a monoclonal antibody product
Shanmuuga Sundaram, Alice Matathia, Jun Qian, et al.
Mabs
|
November 30, 2011
The impact of glycosylation on monoclonal antibody conformation and stability
Kai Zheng, Christopher Bantog, Robert Bayer
Mabs
|
November 30, 2011
Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
Jacqueline M Benson, David Peritt, Bernard J Scallon, et al.
Mabs
|
November 30, 2011
Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions
Yuniel Fernández-Marrero, Alejandro López-Requena
Mabs
|
November 30, 2011
Aggregation, immune complexes and immunogenicity
Roy Jefferis
Page
of 184